“Medicare Part D and Beneficiaries Could Realize Significant Spending Reductions With Increased Biosimilar Use,” (OEI-05-20-00480, March 2022, .pdf format, 33p.).
April 1, 2022
CAAR – US Department of Health and Human Services, Office of Inspector General Report – April 1, 2022
Comments Off on CAAR – US Department of Health and Human Services, Office of Inspector General Report – April 1, 2022
No Comments
No comments yet.
RSS feed for comments on this post.
Sorry, the comment form is closed at this time.
